Pharma Phorum
H2 2025 Sees Pharma and Healthcare Focus on Strategic CollaborationsPublished: 2026-01-02
OrganOx
OrganOx has developed a medical device that maintains human livers for transplants during transport and storage, by providing blood flow, oxygen, nutrients and temperature within physiological parameters.
Companies House ID
06557113
Incorporation Date
2008-04-07
Registered Name
Organox Limited
Status
Active
Employee Count
100-249
Valuation
£102.26 million
Registered Address
125 Wood Street
London
EC2V 7AW
London (Greater)
London
EC2V 7AW
London (Greater)
London
EC2V 7AW
Financials
Summary
| 06 / 2024 | 06 / 2023 | 06 / 2022 | 06 / 2021 | |
|---|---|---|---|---|
| Turnover | £0.00 | £0.00 | £0.00 | £0.00 |
| Operating Profit | £0.00 | £0.00 | £0.00 | £0.00 |
| EBITDA | £0.00 | £0.00 | £0.00 | £0.00 |
| Total Assets | £0.00 | £0.00 | £0.00 | £0.00 |
| Total Liabilities | £0.00 | £0.00 | £0.00 | £0.00 |
| Net Assets | £0.00 | £0.00 | £0.00 | £0.00 |
| Cash | £0.00 | £0.00 | £0.00 | £0.00 |
| Employee count | £0.00 | £0.00 | £0.00 | £0.00 |
Turnover over time
Fundraising
| Fundraising rounds | 14 |
|---|---|
| Amount Raised | £9.99m |
| Transaction | Investor/s | Amount | Stage | Date |
|---|---|---|---|---|
| 15th Jan 2024 | Undisclosed investors | £1.5M | Venture | 15/01/2024 |
| 15th Jan 2024 | Undisclosed investors | £1.5M | Venture | 15/01/2024 |
| 15th Jan 2024 | Undisclosed investors | £1.5M | Venture | 15/01/2024 |
| 15th Jan 2024 | Undisclosed investors | £1.5M | Venture | 15/01/2024 |
| 15th Jan 2024 | Undisclosed investors | £1.5M | Venture | 15/01/2024 |
| 15th Jan 2024 | Undisclosed investors | £1.5M | Venture | 15/01/2024 |
| 15th Jan 2024 | Undisclosed investors | £1.5M | Venture | 15/01/2024 |
| 15th Jan 2024 | Undisclosed investors | £1.5M | Venture | 15/01/2024 |
| 15th Jan 2024 | Undisclosed investors | £1.5M | Venture | 15/01/2024 |
| 15th Jan 2024 | Undisclosed investors | £1.5M | Venture | 15/01/2024 |
| 15th Jan 2024 | Undisclosed investors | £1.5M | Venture | 15/01/2024 |
Unlock the full company profile
Access our live, verified company data on the Beauhurst platform. To get access — and find out exactly what you're missing — get in touch.
Signals and Classifiers
Signals
Classifiers
SIC Codes (2007)
Industries
Key People
Adam Workman
Non-Executive Director
contact@company.comAlex Bronimann
Finance & Human Resource Director
contact@company.comAmit Bose
Chief Technology Officer
contact@company.comAndy Self
Senior Vice President of Business Development & Partnerships
contact@company.comAnnabel Andrew
Vice President of Finance
contact@company.comChris Morris
Clinical Services Director
contact@company.comConstantin Coussios
Co-Founder & Chief Technical Officer
contact@company.comCraig Marshall
Chief Executive Officer
contact@company.comDaniel Martinelli
Vice President of Sales & Marketing, North America
contact@company.comDaniel Voyce
Senior Vice President of Product Development & Innovation
contact@company.comDavid Franks
Chief Human Resources Officer
contact@company.comGeorge Robinson
Non-Executive Director, Part-time
contact@company.comEmployee count over time
News
Oxford Mail
Oxford University Spinout Acquired by Terumo for $1.5 BillionPublished: 2025-11-09
University of Oxford - Medical Sciences Division
Terumo Acquires OrganOx for $1.5bnPublished: 2025-11-03
PRNewsWire
UK Medtech Company OrganOx Achieves Record Exit with $1.5bn ValuationPublished: 2025-08-25
PRNewsWire UK
UK Medtech Company OrganOx Achieves Record Exit with $1.5bn ValuationPublished: 2025-08-25
Finanznachrichten
UK Medtech Company OrganOx Achieves Record Exit with $1.5bn ValuationPublished: 2025-08-25
Contact
| Telephone | 020 0000 0000 |
| contact@company.com | |
| Website | https://www.organox.com/ |
| Social Media |
Similar Companies
Unlock the full company profile
Access our live, verified company data on the Beauhurst platform. To get access — and find out exactly what you're missing — get in touch.